Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eldad Melamed

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
The Lancet. Neurology|August 18, 2006
The mystery of motor asymmetry in Parkinson's diseaseRuth Djaldetti, Ilan Ziv, Eldad Melamed
Handbook of Clinical Neurology|September 24, 2008
Toxic causes of parkinsonismNirit Lev, Eldad Melamed, Daniel Offen
Stem Cells (Dayton, Ohio)|July 11, 2009
Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possibleRan Barzilay, Eldad Melamed, Daniel Offen
Movement Disorders : Official Journal of the Movement Disorder Society|January 5, 2008
Management of motor complications in advanced Parkinson's diseaseEldad Melamed, Ilan Ziv, Ruth Djaldetti
Plos Currents|September 7, 2012
Intrastriatal transplantation of neurotrophic factor-secreting human mesenchymal stem cells improves motor function and extends survival in R6/2 transgenic mouse model for Huntington's diseaseOfer Sadan, Eldad Melamed, Daniel Offen
Current Pharmaceutical Design|October 5, 2006
Anti-inflammatory drugs in the treatment of neurodegenerative diseases: current stateYossi Gilgun-Sherki, Eldad Melamed, Daniel Offen
The Israel Medical Association Journal : IMAJ|January 27, 2004
The hyperperfusion syndrome: an under-recognized complication of carotid endarterectomyJonathan Y Streifler, Diana Israel, Eldad Melamed
Journal of Molecular Neuroscience : MN|November 9, 2010
The "dying-back" phenomenon of motor neurons in ALSMichal Dadon-Nachum, Eldad Melamed, Daniel Offen
Journal of Neurology|March 12, 2004
The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapyYossi Gilgun-Sherki, Eldad Melamed, Daniel Offen
Journal of Molecular Neuroscience : MN|September 23, 2003
Antioxidant treatment in Alzheimer's disease: current stateYossi Gilgun-Sherki, Eldad Melamed, Daniel Offen
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
The Lancet. Neurology|August 18, 2006
The mystery of motor asymmetry in Parkinson's diseaseRuth Djaldetti, Ilan Ziv, Eldad Melamed
Handbook of Clinical Neurology|September 24, 2008
Toxic causes of parkinsonismNirit Lev, Eldad Melamed, Daniel Offen
Stem Cells (Dayton, Ohio)|July 11, 2009
Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possibleRan Barzilay, Eldad Melamed, Daniel Offen
Movement Disorders : Official Journal of the Movement Disorder Society|January 5, 2008
Management of motor complications in advanced Parkinson's diseaseEldad Melamed, Ilan Ziv, Ruth Djaldetti
Plos Currents|September 7, 2012
Intrastriatal transplantation of neurotrophic factor-secreting human mesenchymal stem cells improves motor function and extends survival in R6/2 transgenic mouse model for Huntington's diseaseOfer Sadan, Eldad Melamed, Daniel Offen
Current Pharmaceutical Design|October 5, 2006
Anti-inflammatory drugs in the treatment of neurodegenerative diseases: current stateYossi Gilgun-Sherki, Eldad Melamed, Daniel Offen
The Israel Medical Association Journal : IMAJ|January 27, 2004
The hyperperfusion syndrome: an under-recognized complication of carotid endarterectomyJonathan Y Streifler, Diana Israel, Eldad Melamed
Journal of Molecular Neuroscience : MN|November 9, 2010
The "dying-back" phenomenon of motor neurons in ALSMichal Dadon-Nachum, Eldad Melamed, Daniel Offen
Journal of Neurology|March 12, 2004
The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapyYossi Gilgun-Sherki, Eldad Melamed, Daniel Offen
Journal of Molecular Neuroscience : MN|September 23, 2003
Antioxidant treatment in Alzheimer's disease: current stateYossi Gilgun-Sherki, Eldad Melamed, Daniel Offen
Pageof 12